Prevalence and drug resistance characteristics of carbapenem-resistant Enterobacteriaceae in Hangzhou, China
- PMID: 28687975
- DOI: 10.1007/s11684-017-0529-4
Prevalence and drug resistance characteristics of carbapenem-resistant Enterobacteriaceae in Hangzhou, China
Abstract
With the abuse of antimicrobial agents in developing countries, increasing number of carbapenem-resistant Enterobacteriaceae (CRE) attracted considerable public concern. A retrospective study was conducted based on 242 CRE strains from a tertiary hospital in Hangzhou, China to investigate prevalence and drug resistance characteristics of CRE in southeast China. Bacterial species were identified. Antimicrobial susceptibility was examined by broth microdilution method or epsilometer test. Resistant β-lactamase genes were identified by polymerase chain reaction and sequencing. Genotypes were investigated by phylogenetic analysis. Klebsiella pneumoniae and Escherichia coli were the most prevalent types of species, with occurrence in 71.9% and 21.9% of the strains, respectively. All strains exhibited high resistance (> 70%) against β-lactam antibiotics, ciprofloxacin, trimethoprim-sulfamethoxazole, and nitrofurantoin but exhibited low resistance against tigecycline (0.8%) and minocycline (8.3%). A total of 123 strains harbored more than two kinds of β-lactamase genes. blaKPC-2, blaSHV-11, blaTEM-1, and blaCTX-M-14 were the predominant genotypes, with detection rates of 60.3%, 61.6%, 43.4%, and 16.5%, respectively, and were highly identical with reference sequences in different countries, indicating potential horizontal dissemination. IMP-4 was the most frequent class B metallo-lactamases in this study. In conclusion, continuous surveillance and effective prevention should be emphasized to reduce spread of CRE.
Keywords: Enterobacteriaceae; carbapenem; phylogenetic analysis; β-lactamase genes.
Similar articles
-
Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai.BMC Infect Dis. 2019 Aug 1;19(1):678. doi: 10.1186/s12879-019-4298-3. BMC Infect Dis. 2019. PMID: 31370804 Free PMC article.
-
Molecular characterization and epidemiology of carbapenem non-susceptible Enterobacteriaceae isolated from the Eastern region of Heilongjiang Province, China.BMC Infect Dis. 2018 Aug 22;18(1):417. doi: 10.1186/s12879-018-3294-3. BMC Infect Dis. 2018. PMID: 30134844 Free PMC article.
-
Molecular characterization of carbapenem-resistant Enterobacteriaceae and emergence of tigecycline non-susceptible strains in the Henan province in China: a multicentrer study.J Med Microbiol. 2021 Mar;70(3):001325. doi: 10.1099/jmm.0.001325. Epub 2021 Feb 15. J Med Microbiol. 2021. PMID: 33587030 Free PMC article.
-
The rapid spread of carbapenem-resistant Enterobacteriaceae.Drug Resist Updat. 2016 Nov;29:30-46. doi: 10.1016/j.drup.2016.09.002. Epub 2016 Sep 19. Drug Resist Updat. 2016. PMID: 27912842 Free PMC article. Review.
-
Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review.Ann N Y Acad Sci. 2019 Dec;1457(1):61-91. doi: 10.1111/nyas.14223. Epub 2019 Aug 30. Ann N Y Acad Sci. 2019. PMID: 31469443 Review.
Cited by
-
Tracking the Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in an Emergency Intensive Care Unit by Whole Genome Sequencing.Infect Drug Resist. 2022 Oct 27;15:6215-6224. doi: 10.2147/IDR.S386385. eCollection 2022. Infect Drug Resist. 2022. PMID: 36324669 Free PMC article.
-
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.Front Cell Infect Microbiol. 2022 Mar 15;12:823684. doi: 10.3389/fcimb.2022.823684. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35372099 Free PMC article. Review.
-
Performance Evaluation of BD Phoenix NMIC-413 Antimicrobial Susceptibility Testing Panel for Imipenem, Meropenem, and Ertapenem Against Clinical Carbapenem-Resistant and Carbapenem-Susceptible Enterobacterales.Front Med (Lausanne). 2021 Apr 14;8:643194. doi: 10.3389/fmed.2021.643194. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33937287 Free PMC article.
-
Distribution of β-Lactamase Genes and Genetic Context of bla KPC-2 in Clinical Carbapenemase-Producing Klebsiella pneumoniae Isolates.Infect Drug Resist. 2021 Jan 26;14:237-247. doi: 10.2147/IDR.S290434. eCollection 2021. Infect Drug Resist. 2021. PMID: 33536766 Free PMC article.
-
Genomic Analysis Of A KPC-2-Producing Klebsiella Pneumoniae ST11 Outbreak From A Teaching Hospital In Shandong Province, China.Infect Drug Resist. 2019 Sep 19;12:2961-2969. doi: 10.2147/IDR.S221788. eCollection 2019. Infect Drug Resist. 2019. PMID: 31571948 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
